Literature DB >> 9389724

Typical chronic myelogenous leukemia with e19a2 junction BCR/ABL transcript.

M Briz, C Vilches, R Cabrera, R Forés, M N Fernández.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9389724

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  5 in total

Review 1.  Targeted therapy of chronic myeloid leukemia.

Authors:  Con Sullivan; Cong Peng; Yaoyu Chen; Dongguang Li; Shaoguang Li
Journal:  Biochem Pharmacol       Date:  2010-05-12       Impact factor: 5.858

2.  Concurrence of e1a2 and e19a2 BCR-ABL1 Fusion Transcripts in a Typical Case of Chronic Myeloid Leukemia.

Authors:  Jaehyeon Lee; Dal Sik Kim; Hye Soo Lee; Sam Im Choi; Yong Gon Cho
Journal:  Ann Lab Med       Date:  2017-01       Impact factor: 3.464

Review 3.  Molecular biology of chronic myeloid leukemia.

Authors:  Y Maru
Journal:  Int J Hematol       Date:  2001-04       Impact factor: 2.490

4.  The BCR-ABL oncoprotein potentially interacts with the xeroderma pigmentosum group B protein.

Authors:  N Takeda; M Shibuya; Y Maru
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

5.  The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.

Authors:  S Li; R L Ilaria; R P Million; G Q Daley; R A Van Etten
Journal:  J Exp Med       Date:  1999-05-03       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.